Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestoration
Authors:
- 1 January 2011
- journal article
- Published by Elsevier in Brain Research
- Vol. 1370, 80-88
Abstract
No abstract availableKeywords
Funding Information
- USPHS (NS19608, NS45698, R01TW008040)
- Michael J. Fox Foundation
- U.S. Army (DAMD17-03-0479)
- USPHS (NS047831)
- USPHS (NS45698)
This publication has 60 references indexed in Scilit:
- Reversible neurochemical changes mediated by delayed intrastriatal glial cell line‐derived neurotrophic factor gene delivery in a partial Parkinson's disease rat modelThe Journal of Gene Medicine, 2009
- GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's diseaseNeuroscience Letters, 2007
- A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigraExperimental Neurology, 2006
- Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigraJournal of Neurochemistry, 2004
- Effects of GDNF on 6‐OHDA‐induced death in a dopaminergic cell line: Modulation by inhibitors of PI3 kinase and MEKJournal of Neuroscience Research, 2003
- Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neuronsJournal of Comparative Neurology, 1995
- Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivoNeuroscience Letters, 1994
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993
- Effects ofl-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated ratsBrain Research, 1990
- A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer diseaseAnnals of Neurology, 1981